Good news: warmly congratulate Professor Jiandong Jiang on his election as an academician of the Chinese Academy of Engineering
On November 18, 2021, Professor Jiandong Jiang was elected academician of the Chinese Academy of Engineering, the second academician of our Institute.
Jiandong Jiang, male, born in December 1958, member of the peasants' and workers' Democratic Party, researcher of the IMB CAMS, Distinguished professor of Peking Union Medical College, President of the Institute of pharmaceutical research,CAMS, member of the 13th Committee of the CPPCC National Committee, member of the Standing Committee of the 16th China Peasants and Workers Democratic Party, and member of the 13th Committee of the Beijing Municipal CPPCC, Vice chairman and member of the Standing Committee of the 13th Beijing Municipal Committee of the Chinese peasants and Workers Democratic Party. He graduated from Nanjing Medical University in 1981, received his master degree from China Union Medical College in 1985 and received doctor degree from Shanghai Medical College of Fudan University.
From March 1981 to February 1982, he served as a resident of Nanjing Children's Hospital. From February 1988 to February 1989, he served as an assistant researcher in the Institute of Dermatology, Chinese Academy of Medical Sciences. From March 1989 to February 1999, he engaged in post doctoral research at Mount Sinai School of medicine, New York University, and served as assistant professor and director of the Department of medicine. From February 1998 to October 2010, he successively served as the researcher, research director, assistant director, vice director and director of IMB, CAMS. From October 2010 to January 2021, he served as the director of the Institute of Material Medica, CAMS. From December 2011 to now, he served as the director of the Institute of pharmaceutical research, CAMS. From October 2010 to now, he has served as research director of Virus Research Department and researcher of IMB, CAMS.
Research direction and academic contribution:
Professor Jiandong Jiang has been engaged in basic pharmaceutical theory and new drug research and development for a long time. He discloses that berberine, an antibacterial drug in China, is a lipid-lowering (and hypoglycemic) drug with a new mechanism, reveals the chemical and biological principles of berberine. The new function of berberine has been confirmed and applied to clinic. His efficacy cloud theory has attracted extensive attention at home and abroad and has become a model of original drug research in China. He has established advanced anti-infective drug technology system, and proposed and put into practice the host-directed antiviral theory, and made important breakthroughs in the research of anti-infective drugs. His research on an anti-SARS-CoV-2 drug has entered the phase III clinical trial stage.
He has published over 290 SCI papers, obtained 48 patent authorizations and 7 new drug certificates or clinical approvals, and won several awards such as Second Class National Natural Science Award. He has been long insisted on the research, development, theoretical exploration and especially the clinical application of Chinese original new drugs, and made outstanding contributions to pharmaceutical development of China.